Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects

Clinical trial NCT06584812 · COMPLETED

Trial details

NCT number: NCT06584812
Sponsor: Tianjin Institute of Pharmaceutical Research Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Coronary Syndrome Ischemic Stroke

Start date: 2024-09-09
Primary completion: 2024-12-05
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.